UNSPSC 85552812: Supplement right lacrimal duct with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right lacrimal duct with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 08UX37Z

UNSPSC 85552812 Supplement right lacrimal duct with autologous tissue substitute, percutaneous approach is a Commodity code that shows no meaningful recent state and local procurement activity aligned with its nominal clinical scope. The recent opportunities tagged under this code include independent medical evaluation services for pension disability determinations, occupational medical surveillance, pharmacy benefit management, surgical care networks, emergency services for detained youth, and temporary health professional staffing—none of which involve lacrimal duct procedures or tissue-substitute implants. This appears to be a classification mismatch rather than a reflection of actual buying under the code; state and local procurement bodies do not appear to be soliciting lacrimal duct augmentation services or related surgical supplies under this taxonomy entry.

The geographic and issuing-body spread in the tagged opportunities spans Arizona (City of Phoenix), California (City of Long Beach and County of Santa Clara), Washington (Washington State Department of Transportation), Texas (Harris County), and Florida (Collier County)—a broad geographic footprint across municipal, county, and state health and retirement agencies. However, the lack of lacrimal duct or ophthalmic surgical procedure solicitations in the recent record suggests that either the code is rarely used for state and local procurement, or opportunities are being filed under different UNSPSC codes. A firm evaluating this code for business development should verify whether state and local governments in target regions classify ophthalmic implants or surgical services differently in their procurement systems, as the current tagging provides no actionable signals for pursuit.